TNF‐α Inhibitors and HBV Reactivation Risk in HBsAg−/Anti‐HBc+ Patients: A Systematic Review and Meta‐Analysis

Authors

Institutions

Publication Details

Journal
Liver International
Published
2026-02-02
DOI
https://doi.org/10.1111/liv.70532
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TNF‐α Inhibitors and HBV Reactivation Risk in HBsAg−/Anti‐HBc+ Patients: A Systematic Review and Meta‐Analysis

Ping‐Hung Ko, Chih‐Wei Tseng, Meng Hsuan Kuo, Chen‐Chou Lee
Liver International
Hepatitis B Virus Studies
article

TNF‐α Inhibitors and HBV Reactivation Risk in HBsAg−/Anti‐HBc+ Patients: A Systematic Review and Meta‐Analysis

Ping‐Hung Ko, Chih‐Wei Tseng, Meng Hsuan Kuo, Chen‐Chou Lee
article en

Abstract

No abstract available for this paper.
Liver InternationalVol. 46(3)
Tzu Chi University (TW), Taipei Tzu Chi Hospital (TW)
Good health and well-being
Openalex Percentile: Top 68%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TNF‐α Inhibitors and HBV Reactivation Risk in HBsAg−/Anti‐HBc+ Patients: A Systematic Review and Meta‐Analysis — Ping‐Hung Ko, Chih‐Wei Tseng, et al. · Liver International (2026) | TGRS Research Map | TGRS